Open AccessTXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients
Author(s) -
Agnieszka Magdalena Borowiec,
Adam Właszczuk,
Edyta Olakowska,
Joanna Lewin–Kowalik
Publication year - 2022
Publication title -
medicine and pharmacy reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.35
H-Index - 16
eISSN - 2668-0572
pISSN - 2602-0807
DOI - 10.15386/mpr-2187
Subject(s) - txnip , thioredoxin interacting protein , endocrinology , medicine , insulin resistance , diabetes mellitus , downregulation and upregulation , thioredoxin , cancer research , oxidative stress , chemistry , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom